ALEJANDRO ARROLIGA to Case-Control Studies
This is a "connection" page, showing publications ALEJANDRO ARROLIGA has written about Case-Control Studies.
Connection Strength
0.121
-
Association between hyperhomocysteinemia and primary pulmonary hypertension. Respir Med. 2003 Jul; 97(7):825-9.
Score: 0.033
-
Vaccine Effectiveness Against Acute Respiratory Illness Hospitalizations for Influenza-Associated Pneumonia During the 2015-2016 to 2017-2018 Seasons: US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN). Clin Infect Dis. 2022 04 28; 74(8):1329-1337.
Score: 0.030
-
Circulating miRNAs as potential marker for pulmonary hypertension. PLoS One. 2013; 8(5):e64396.
Score: 0.016
-
Economic burden of ventilator-associated pneumonia based on total resource utilization. Infect Control Hosp Epidemiol. 2010 May; 31(5):509-15.
Score: 0.013
-
Alterations of cellular bioenergetics in pulmonary artery endothelial cells. Proc Natl Acad Sci U S A. 2007 Jan 23; 104(4):1342-7.
Score: 0.010
-
Nitric oxide blocks nuclear factor-kappaB activation in alveolar macrophages. Am J Respir Cell Mol Biol. 1999 Sep; 21(3):311-6.
Score: 0.006
-
Risk factors for an outbreak of multi-drug-resistant Acinetobacter nosocomial pneumonia among intubated patients. Chest. 1999 May; 115(5):1378-82.
Score: 0.006
-
Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients. Clin Infect Dis. 1998 Mar; 26(3):753-5.
Score: 0.006